DNM1L and breast carcinoma: Drp1 inhibitors like Driptor1 were employed against breast cancer cells, which show not only that the mitochondrial dynamics-mediated pathway is useful in designing anti-cancer therapy [12] but also that mitochondrial fission facilitates the survival, apoptosis, and drug resistance of breast cancer cells [13].